Reducing Stroke Risk in your NVAF Patients: Is LAAC Elective or Essential?
Douglas N. Gibson, MD, Gwen S. Janczyk, PA, and Kristi C. Pangborn, NP
Saturday, April 24, 2021
12:30-1:30 p.m. PT
12:30 p.m.
|
Identification and Rationale of the Appropriate Patient for Left Atrial Appendance Closure (LACC) Kristi C. Pangborn, NP
|
12:50 p.m.
|
Pre-Implant to Follow-up: Safety and Efficiencies in Patient Workflow Gwen S. Janczyk, PA
|
1:10 p.m.
|
WATCHMAN FLX: New Innovations in LAAC Therapy for NVAF Patients Douglas Gibson, MD
|
1:30 p.m.
|
Adjourn
|
Please note: all times listed are Pacific Standard Time (PDT).